NIH-funded research NIH-funded research

Exploring how bacteria influence insulin signaling in animals

Official title: IDENTIFYING MICROBIAL MECHANISMS THAT REGULATE ANIMAL INSULIN SIGNALING

Funded at Van Andel Research Institute · NIH-10680954 · Data updated 2026-11-12

This study is looking at how certain gut bacteria can help control insulin release, which is important for people with Type 2 diabetes, and it aims to find specific bacteria that could lead to new treatments for better managing the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVan Andel Research Institute
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$1,710,000
NIH project number1DP2DK139569-01
Project IDNIH-10680954 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with Type 2 diabetes or those at risk of developing insulin resistance.

Less likely to help

Patients with Type 1 diabetes or other forms of diabetes not related to insulin resistance may not benefit from this research.

What this research studies

This research investigates the role of intestinal bacteria in regulating insulin release, which is crucial for managing conditions like Type 2 diabetes. Using a novel model organism, C. elegans, the researchers aim to identify specific bacterial strains that can modify insulin signaling in vivo. The study employs advanced techniques such as transposon mutagenesis to pinpoint the bacterial genes responsible for these effects. By engineering probiotics to enhance insulin regulation, the research seeks to uncover new therapeutic avenues for diabetes management.

Why it matters

Potential benefit: If successful, this research could lead to new probiotic treatments that improve insulin sensitivity and help manage Type 2 diabetes.

How similar studies have gone: Previous research has shown promising results in understanding the gut microbiome's role in metabolic processes, suggesting potential for success in this novel approach.

Where this research is happening

  • Van Andel Research Institute
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Burton, Nicholas O — Van Andel Research Institute
  • Study coordinator: Burton, Nicholas O

Related research

Other NIH-funded projects on the same topics.

  • Histone mutations in cancer pathogenesis

    A cancer-focused study looks at how changes in histone genes found in patients may drive tumor growth and interact with other cancer mutations.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11519685

  • circSATB2: a new regulator in arsenic-related cancer

    A new gene-related mechanism linked to arsenic exposure and cancer is being studied to understand how a circular RNA from SATB2 may influence cancer development.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11467706

  • Bacteria that influence insulin signaling and Type 2 diabetes

    Researchers will study gut bacteria that may change how insulin works in the body, with a focus on diabetes risk.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11455824

  • Understanding how amyloid plaques form in Alzheimer's disease

    A research project will look at how misfolded amyloid proteins build up in the brains of people and mouse models with Alzheimer’s disease to uncover new clues for diagnosis and treatment.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11448261

  • How DNA methylation patterns are kept in colon cancer and what happens when they’re disrupted

    Researchers are studying how the molecular marks that control gene activity are maintained in colon cancer and how breaking these marks affects cancer growth and treatment response.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11447596

  • ER quality control across cell types with unique ER shapes

    A scientist will study how the endoplasmic reticulum keeps cells healthy by managing its structure and stress responses in different cell types, including neurons.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11428039

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.